다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Cyclacel Pharmaceuticals Inc (CYCCP)
Cyclacel Pharmaceuticals Inc (CYCCP) 뉴스

CYCCP

Cyclacel Pharmaceuticals (CYCCP)

Cyclacel Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CYCCP

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/17	22:56	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/05/15	06:12	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/05/15	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/05/15	05:05	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/05/14	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/05/14	05:05	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/05/08	22:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/05/08	10:56	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/05/08	10:53	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/05/08	10:52	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/05/07	06:26	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/05/03	05:30	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/05/01	02:51	AllPennyStocks.com	$8 Million Private Placement Announcement Sends Biotech Flying	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/04/30	20:00	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Announces $8.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/04/01	22:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancer	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/03/20	05:05	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/03/14	05:05	GlobeNewswire Inc.	Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/03/07	23:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/03/06	23:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/02/20	23:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conference	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/02/15	06:31	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/02/15	06:06	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/02/15	00:09	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/02/14	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/02/14	05:47	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/02/08	07:03	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/02/01	06:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/01/30	23:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/01/30	23:15	GlobeNewswire Inc.	Cyclacel Pharmaceuticals Announces the Appointment of Brian Schwartz, M.D. as Chief Medical Officer	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc
2024/01/20	06:58	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:CYCCP	Cyclacel Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:CYCCP

1 2 3 4 5 6 7 8 9 10 다음 >>

Invesco QQQ Trust Series 1

Health Care Select Sector

Deutsche Telekom (QX)

JP Morgan Chase

Gold vs US Dollar

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관